Policy | May 25, 2021
Cipla to market Roche's Antibody Cocktail in India
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
The tablets will be manufactured and marketed under Vivimed’s brand name “Favulous” across India
NATCO's partner BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks.
Fluphenazine Hydrochloride Tablets, USP are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
Alkem’s semaglutide comes in a pre-filled disposable injection pen containing four doses for a month, priced at Rs. 1,800
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
Subscribe To Our Newsletter & Stay Updated
